ROTORK PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 337.8 GBX | +0.30% |
|
+0.12% | +4.39% |
| May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
| May. 01 | JPMorgan Lifts Rotork PT, Keeps Rating at Neutral | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,919 | 2,772 | 3,068 | 2,635 | 2,782 | 2,885 | - | - |
| Enterprise Value (EV) 1 | 2,813 | 2,594 | 2,954 | 2,529 | 2,782 | 2,751 | 2,698 | 2,639 |
| P/E ratio | 31 x | 29.7 x | 38.8 x | 28.4 x | 24.5 x | 24.5 x | 21.5 x | 19.9 x |
| Yield | 1.85% | 1.98% | 1.79% | 2.19% | - | 2.26% | 2.43% | 2.61% |
| Capitalization / Revenue | 4.36 x | 4.59 x | 5.39 x | 4.1 x | 3.87 x | 3.84 x | 3.64 x | 3.48 x |
| EV / Revenue | 4.2 x | 4.29 x | 5.19 x | 3.94 x | 3.87 x | 3.66 x | 3.4 x | 3.18 x |
| EV / EBITDA | 16.8 x | 16.3 x | 20.3 x | 15.8 x | 15.4 x | 14.5 x | 13.3 x | 12.2 x |
| EV / FCF | 20.5 x | 23.2 x | 44 x | 54.2 x | - | 25.5 x | 21.8 x | 19.8 x |
| FCF Yield | 4.87% | 4.32% | 2.27% | 1.84% | - | 3.93% | 4.58% | 5.05% |
| Price to Book | 5.4 x | 4.76 x | 5.81 x | 4.48 x | - | 4.53 x | 4.09 x | 3.69 x |
| Nbr of stocks (in thousands) | 871,457 | 871,819 | 858,950 | 859,293 | 859,583 | 856,631 | - | - |
| Reference price 2 | 3.350 | 3.180 | 3.572 | 3.066 | 3.236 | 3.368 | 3.368 | 3.368 |
| Announcement Date | 3/3/20 | 3/2/21 | 3/1/22 | 2/28/23 | 3/5/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 669.3 | 604.5 | 569.2 | 641.8 | 719.2 | 751.6 | 792.8 | 829.8 |
| EBITDA 1 | 167.4 | 158.9 | 145.4 | 159.6 | 180.4 | 189.1 | 203 | 215.6 |
| EBIT 1 | 151 | 142.5 | 128.1 | 143.2 | 164.5 | 174.5 | 188 | 200 |
| Operating Margin | 22.56% | 23.58% | 22.5% | 22.32% | 22.87% | 23.21% | 23.71% | 24.1% |
| Earnings before Tax (EBT) 1 | 124.1 | 122 | 105.9 | 124.1 | 150.6 | 159.9 | 179.5 | 192.4 |
| Net income 1 | 94.1 | 93.33 | 80.24 | 93.2 | 113.1 | 118 | 134 | 144.8 |
| Net margin | 14.06% | 15.44% | 14.1% | 14.52% | 15.73% | 15.7% | 16.9% | 17.44% |
| EPS 2 | 0.1080 | 0.1070 | 0.0920 | 0.1080 | 0.1320 | 0.1374 | 0.1565 | 0.1693 |
| Free Cash Flow 1 | 137.1 | 112 | 67.1 | 46.61 | - | 108.1 | 123.6 | 133.2 |
| FCF margin | 20.49% | 18.52% | 11.79% | 7.26% | - | 14.38% | 15.59% | 16.05% |
| FCF Conversion (EBITDA) | 81.93% | 70.49% | 46.14% | 29.2% | - | 57.17% | 60.91% | 61.78% |
| FCF Conversion (Net income) | 145.72% | 119.99% | 83.62% | 50.01% | - | 91.62% | 92.29% | 92.03% |
| Dividend per Share 2 | 0.0620 | 0.0630 | 0.0640 | 0.0670 | - | 0.0763 | 0.0818 | 0.0878 |
| Announcement Date | 3/3/20 | 3/2/21 | 3/1/22 | 2/28/23 | 3/5/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 350.7 | 283.2 | 321.3 | 288.3 | 280.9 | 280 | 361.8 | 334.7 | 384.5 |
| EBITDA | - | - | - | 71.62 | 73.79 | - | - | - | - |
| EBIT 1 | 83.77 | 61.24 | - | 62.74 | 65.34 | 53.3 | 89.94 | 65.29 | 99.18 |
| Operating Margin | 23.88% | 21.62% | - | 21.76% | 23.26% | 19.04% | 24.86% | 19.51% | 25.8% |
| Earnings before Tax (EBT) | 71.82 | - | - | - | 51.78 | - | 79.51 | 60.25 | - |
| Net income | 54.2 | - | - | - | 39.36 | - | 59.46 | 45.69 | - |
| Net margin | 15.45% | - | - | - | 14.01% | - | 16.43% | 13.65% | - |
| EPS | - | - | - | - | 0.0450 | - | 0.0690 | 0.0530 | - |
| Dividend per Share | 0.0390 | 0.0390 | 0.0240 | 0.0235 | 0.0405 | 0.0240 | 0.0430 | 0.0255 | - |
| Announcement Date | 3/3/20 | 8/4/20 | 3/2/21 | 8/3/21 | 3/1/22 | 8/2/22 | 2/28/23 | 8/8/23 | 3/5/24 |
1GBP in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 106 | 178 | 114 | 106 | - | 134 | 187 | 246 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 137 | 112 | 67.1 | 46.6 | - | 108 | 124 | 133 |
| ROE (net income / shareholders' equity) | 17.9% | 19.4% | 17.7% | 19.5% | - | 21% | 20.9% | 20.3% |
| ROA (Net income/ Total Assets) | 12.7% | 14.7% | 13.8% | 15.6% | - | 15.8% | 16.4% | 16.2% |
| Assets 1 | 740.2 | 636.8 | 581.9 | 595.8 | - | 745.1 | 817.3 | 892.7 |
| Book Value Per Share 2 | 0.6200 | 0.6700 | 0.6100 | 0.6800 | - | 0.7400 | 0.8200 | 0.9100 |
| Cash Flow per Share 2 | 0.1800 | 0.1600 | 0.1000 | 0.0700 | - | 0.1500 | 0.1700 | 0.1800 |
| Capex 1 | 19.2 | 25.3 | 18.3 | 12.9 | - | 19 | 17.2 | 17.3 |
| Capex / Sales | 2.87% | 4.18% | 3.22% | 2.01% | - | 2.53% | 2.16% | 2.09% |
| Announcement Date | 3/3/20 | 3/2/21 | 3/1/22 | 2/28/23 | 3/5/24 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
3.368
GBP
Average target price
3.497
GBP
Spread / Average Target
+3.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.08% | 3.63B | |
| -5.39% | 5.95B | |
| -13.26% | 350M | |
| +10.19% | 186M | |
| -30.87% | 180M | |
| -1.89% | 146M | |
| +1.45% | 52.82M |
- Stock Market
- Equities
- ROR Stock
- Financials Rotork plc
